Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21

Class I - Dangerous
💊 Drugs Recalled: April 27, 2016 Novo Nordisk Prescription Drugs Nationwide

What Should You Do?

  1. Check if you have this product:
    Lot Number FC70222
  2. Do not eat it: Even if it looks and smells fine, do not consume this product.
  3. Throw it away or return it: You can return the product to the store for a full refund.
  4. Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
  5. Report problems: Report any issues to the FDA's Safety Reporting Portal.

⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.

Recall Details

Company:
Novo Nordisk Inc
Reason for Recall:
Defective Delivery System; may have a low frequency assembly fault which may result in pens block during the so-called "air shot" step
Classification:
Class I - Dangerous

Dangerous or defective products that predictably could cause serious health problems or death.

Status:
terminated

Product Information

Full Description:

Norditropin FlexPro Somatropin (rDNA origin) injection, 30 mg/3 mL Prefilled Pen, Rx only, Novo Nordisk Inc., Plainsboro, NJ --- NDC 0169-7703-21

Product Codes/Lot Numbers:

Lot Number FC70222

Official Source

Always verify recall information with the official FDA source:

View on FDA.gov

FDA Recall Number: D-0956-2016

Related Recalls

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Mar 22, 2021 Prescription Drugs Nationwide View Details →

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Mar 22, 2021 Prescription Drugs Nationwide View Details →

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Mar 22, 2021 Prescription Drugs Nationwide View Details →